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lycoprotein fucosylation enables fringe-dependent
modulation of signal transduction by Notch trans-
membrane  receptors, contributes to selectin-
dependent leukocyte trafﬁcking, and is faulty in leukocyte
adhesion deﬁciency (LAD) type II, also known as congenital
disorder of glycosylation (CDG)-IIc, a rare human disorder
characterized by psychomotor defects, developmental
abnormalities, and leukocyte adhesion defects. We report
here that mice with an induced null mutation in the FX
locus, which encodes an enzyme in the de novo pathway
for GDP–fucose synthesis, exhibit a virtually complete
deﬁciency of cellular fucosylation, and variable frequency
of intrauterine demise determined by parental FX genotype.
G
 
Live-born FX(
 
 
 
/
 
 
 
) mice exhibit postnatal failure to thrive
that is suppressed with a fucose-supplemented diet.
FX(
 
 
 
/
 
 
 
) adults suffer from an extreme neutrophilia, myelo-
proliferation, and absence of leukocyte selectin ligand
expression reminiscent of LAD-II/CDG-IIc. Contingent
restoration of leukocyte and endothelial selectin ligand
expression, general cellular fucosylation, and normal
postnatal physiology is achieved by modulating dietary
fucose to supply a salvage pathway for GDP–fucose synthesis.
Conditional control of fucosylation in FX(
 
 
 
/
 
 
 
) mice
identiﬁes cellular fucosylation events as essential con-
comitants to fertility, early growth and development, and
leukocyte adhesion.
 
Introduction
 
Mammalian cell surface glycans are characterized by enormous
structural diversity and by dynamic tissue-specific and develop-
mentally regulated expression patterns. Rare carbohydrate-
deficient glycoprotein syndromes accounted for by mutations
in loci that control glycosylation, demonstrate that deficient
or aberrant glycosylation pathways are associated with serious
and widespread disruptions in organ physiology (Freeze,
2001). Similarly, mice with induced null mutations in genes
that determine glycosylation pathways inform us that complex-
type N-glycans are required for normal mammalian develop-
ment (Metzler et al., 1994), for example, and that several
distinct, precisely controlled, tissue- or cell type–specific
terminal modifications of O-glycans are required for immune
system function (Lowe, 2001). Nonetheless, functional
correlates remain to be assigned to the majority of glycan
structural diversity in mammals.
Fucose is a monosaccharide found widely in the plant and
animal kingdoms (Staudacher et al., 1999). In humans and
other mammals, fucose is a component of many surface-
localized and secreted molecules, where it decorates the terminal
portions of N-, O-, and lipid-linked glycans, modifies the
core of some N-linked glycans, and is linked covalently to
some serine and threonine residues (Fig. 1). Fucosylation of
mammalian glycans is catalyzed by distinct fucosyltransferases,
numbering roughly a dozen or fewer in each mammalian
species, with catalytic activities characterized by precise
specificity for glycan precursors and a requirement for the sugar
nucleotide substrate GDP–fucose (Fig. 1; Oriol et al., 1999).
Terminal 
 
 
 
(1,2)-fucosylated glycans in humans contribute to
the ABO, Secretor, and Lewis blood group antigens (Lowe,
2000). In the gastrointestinal tract, fucosylation-dependent
microbe–epithelial cell interactions are assigned a role in the
attachment and pathogenesis of 
 
Helicobacter pylori
 
 infection
(Hooper and Gordon, 2001), and in a commensal relationship
between the anaerobic bacterium 
 
Bacteroides
 
 
 
thetaiaotomicron
 
and its rodent host (Hooper and Gordon, 2001). Fucosylation
of the glycans that decorate the leukocyte and endothelial cell
counter receptors for the selectin family of cell adhesion
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molecules are prominent determinants of the activities of
these counter receptors, and thereby control selectin-depen-
dent leukocyte adhesion and trafficking events in the
mammal (Homeister et al., 2001). Fucose also represents
an apparently essential component of glycans that decorate
the Notch family of transmembrane receptors, and whose
structures are determined in part by the Fringe family of
glycosyltransferases. These fucose-dependent glycans can
modulate signal transduction events initiated by interac-
tions between Notch and its ligands (Bruckner et al., 2000;
Moloney et al., 2000b).
Aberrant fucosylation is associated with pathophysiology
in leukocyte adhesion deficiency (LAD)* type II, also known
as congenital disorder of glycosylation (CDG) type IIc
(Freeze, 2001), a rare human disorder characterized by psy-
chomotor defects, developmental abnormalities, and leuko-
cyte adhesion defects (Etzioni et al., 1992; Frydman et al.,
1992; for review see Becker and Lowe, 1999). Missense mu-
tations in a Golgi-localized GDP–fucose transporter account
for defective fucosylation in these individuals (Lubke et al.,
2001; Luhn et al. 2001). Based on our understanding of the
contribution by fucosylation to the activities of leukocyte se-
lectin counter receptors (Homeister et al., 2001), the leuko-
cyte adhesion defect in LAD-II/CDG-IIc can be clearly
assigned to defective fucosylation. Nonetheless, the patho-
physiological basis for the many developmental, psychomo-
tor, and morphological abnormalities in these patients
(Freeze, 2001) remains mysterious.
Intentional manipulation of glycan fucosylation by mod-
ulating fucosyltransferase expression in cellular contexts
(Lowe, 2000) or chronically and irreversibly in the context
of an intact mammal (Domino et al., 2001; Homeister et
al., 2001) have proven informative in the discovery of
functions for fucosylated glycans. Similarly, an ability to
control cellular and organ fucosylation intentionally, but
acutely and reversibly, may advance efforts to unveil func-
tions for fucosylated glycans in novel contexts, to assign
function in contexts where fucosylated glycans are inferred
to contribute to development (Feizi, 1985; Fenderson et
al., 1986) and fertility (Dell et al., 1999), and to further
define contributions made by fucosylated glycans in the
previously explored contexts discussed above. Towards
these ends, we report here the construction and character-
ization of mice with an induced mutation in the locus
encoding GDP-4-keto-6-deoxymannose 3,5-epimerase-4-
reductase (also known as FX) (Szikora et al., 1990; Cam-
 
*Abbreviations used in this paper: CDG, congenital disorder of glycosyla-
tion; CFU, colony-forming unit; dpc, days postcoitum; ES, embryonic stem;
GM, granulocyte-macrophage; GMD, GDP-mannose 4,6-dehydratase;
HEV, high endothelial venule; LAD, leukocyte adhesion deficiency; M/E,
myeloid–erythroid; PSA, 
 
Pisum sativum 
 
agglutinin;
 
 
 
WT, wild-type.
Figure 1. Fucosylation pathways in mammals. Two different cytosolic pathways lead to formation of GDP–fucose. The constitutively active 
de novo pathway converts GDP–mannose into GDP–fucose via oxidation, epimerization, and reduction catalyzed by two enzymes (GMD and FX). 
The salvage pathway initiates with free fucose, delivered to the cytosol from extracellular sources (shown) or from intracellular (lysosomal) 
sources (not depicted). GDP–fucose from this pathway is then transported into the Golgi lumen where it is used by fucosyltransferases, whose 
catalytic domains reside within the Golgi lumen. Fucosylation, and other glycosylation events lead to the synthesis of cell surface glycoconjugates 
with structures (highlighted in color) that contribute to selectin recognition (Lowe, 2001), Notch signaling (Moloney et al., 2000b), interactions 
between microbes and their mammalian hosts (Hooper and Gordon, 2001), or to binding by pea lectin (PSA). 
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ardella et al., 1995; Tonetti et al., 1996), an enzyme
thought to be essential to the constitutive and primary
pathway for the synthesis of the fucosyltransferase substrate
GDP–fucose (Becker and Lowe, 1999). In the adult
mouse, homozygosity for the FX-null allele confers a virtu-
ally complete dependence on a fucose-dependent salvage
pathway for GDP–fucose synthesis, enables intentional,
conditional, and reversible control of glycan fucosylation
in the animal’s cells and organs, and reveals a requirement
for fucosylated glycans in fertility, growth and develop-
ment, leukocyte adhesion, homeostasis in the gastrointesti-
nal tract and hematopoietic physiology.
 
Results
 
The FX(
 
 
 
/
 
 
 
) genotype is associated with a partially 
penetrant embryonic lethal phenotype
 
Embryonic stem (ES) cell transfectants containing homolo-
gous integration of the targeting vector were identified by
Southern blot analyses (Fig. 2). Male chimeras derived from
correctly targeted ES clones generated progeny heterozygous
for the mutant FX allele. Mice heterozygous for the targeted
allele are normal in size and exhibit grossly normal behavior.
In matings between male and female FX heterozygotes, fe-
male and male progeny were equally represented, but only
Figure 2. Targeted deletion of the FX 
locus. (A) Structure of WT and null FX loci. 
Thicker lines denote exons. A neomycin 
expressing cassette (Maly et al., 1996) was 
inserted between Sac I restriction sites, 
eliminating exons 4–6 of the WT locus. 
(B) Southern blot analysis of WT and FX 
null loci (Materials and methods). 
Southern blots were prepared using 
EcoRV-digested genomic DNA from WT 
ES cells (lane ES D3), from a targeted ES 
line (clone D3D; lane ES FXD3D; 
heterozygous for the mutant FX allele), 
from heterozygous male and female 
progeny of chimeric mice derived from 
ES clone FXD3D (lanes  /  Male and 
 /  Female), and from littermates 
derived from this breeding triangle 
(Progeny). Blots were hybridized with 
probe A (top), stripped, and rehybridized 
with probe C (bottom). Fragments 
corresponding to the WT and 
3,5-epimerase/4-reductase alleles migrate 
at 8.9 and 5.7 Kb, respectively. Reference 
fragments are designated in Kb. 
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six FX(
 
 
 
/
 
 
 
) mice (three males, three females) were identi-
fied in 360 progeny genotyped at weaning (Table I). A slight
deficit of heterozygotes was observed, relative to the ex-
pected Mendelian distribution, indicating a partial loss of
heterozygotes and a selective and profound loss of homozy-
gous-null embryos. Among embryos collected from females
impregnated in timed matings, a normal Mendelian distri-
bution was observed at 3.5 d postcoitum (dpc). Thereafter, a
relative loss of FX(
 
 
 
/
 
 
 
) progeny was observed at 12.5 dpc,
and a further loss at 16.5 dpc, such that immediately prior
to birth, the number of FX(
 
 
 
/
 
 
 
) embryos was 
 
 
 
28% of
the predicted number (Table II). A further and substantial
apparent loss of FX(
 
 
 
/
 
 
 
) progeny was also evident during
the weaning period (Table II).
Considered together with the predicted biochemical de-
fect in the mice (Fig. 1), these observations suggested that
absence of fucosylated glycans is associated with and perhaps
accounts for the embryonic lethality. In an effort to circum-
vent the embryonic lethal phenotype by reconstitution of fu-
cosylation via the salvage pathway for GDP–fucose syn-
thesis, mating, gestation, and postpartum activities were
completed in cages with water supplemented to 100 mM fu-
cose. The frequency of null progeny in these matings at
weaning (Table III) was essentially identical to that observed
without fucose supplementation, or when matings were
done with females gestated with diets supplemented with fu-
cose only in chow, or in both chow and water (unpublished
data). These observations indirectly indicate that dietary fu-
cose is not able to reconstitute fucosylation in FX(
 
 
 
/
 
 
 
) em-
bryos to a degree that permits their survival to term. Fucose
 
Table I. 
 
Progeny of FX(
 
 
 
/
 
 
 
) 
 
 
 
 FX(
 
 
 
/
 
 
 
) intercross
Genotype Male Female Total % Observed  % Expected
 
 
 
/
 
 
 
58 69 127 35.3 25
 
 
 
/
 
 
 
116 111 227 63.0 50
 
 
 
/
 
 
 
3 3 6 1.7 25
No fucose was added to chow or water. Genotype of progeny mice were
determined at weaning (postnatal day 21). Chi-square analysis was used to
compare the observed values with values predicted by Mendelian
inheritance patterns. P
 
  
 
 10
 
 
 
3
 
.
Table II. 
 
Genotypes of embryos derived from FX(
 
 
 
/
 
 
 
) 
 
 
 
FX(
 
 
 
/
 
 
 
) intercross
Days postcoitus
Genotype 3.5 12.5 14.5 16.5 18.5 Weaning
 
a
 
 
 
/
 
 
 
19% 30% 37% 31% 29% 35.3%
 
 
 
/
 
 
 
54% 55% 50% 64% 64% 63%
 
 
 
/
 
 
 
27% 15% 13% 5% 7% 1.7%
 
n
 
52 130 109 125 113 360
P value
 
b
 
0.630 0.036 0.002
 
 
 
10
 
 
 
3
 
 
 
10
 
 
 
3
 
 
 
10
 
 
 
3
 
No fucose was added to chow or water.
 
a
 
Postnatal day 21.
 
b
 
Chi-square analysis was used to compare the observed values with the
values predicted by Mendelian inheritance patterns. 
Figure 3. Expression of fucosylated glycans in the spleen in FX( / ) embryos. WT or FX ( / ) embryos were obtained at 18.5 d dpc from 
a mating between an FX ( / ) male and an FX( / ) female reared without fucose supplementation. Fuc-TIV( / )/Fuc-TVII( / ) 18.5 dpc 
embryos were derived from Fuc-TIV( / )/Fuc-TVII( / ) intercrosses (Homeister et al., 2001). Frozen sections of the embryonic spleens were 
stained (Materials and methods) with anti–Gr-1 antibody (top). An adjacent section was stained with an E-selectin–IgM chimera in buffer 
containing 2 mM CaCl2 (middle) or in buffer containing 5 mM EDTA (bottom). EDTA-resistant staining observed with the E-selectin–IgM chimera 
is due to the secondary anti–human IgM used to detect the chimera (unpublished data). (10  final magnification). 
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supplementation during the postterm/preweaning interval
also does not significantly enhance survival to weaning, as
indicated by a comparison of the data on the survival rate to
weaning in Tables I and III, and by experiments in which
the rate of survival of FX(
 
 
 
/
 
 
 
) mice between days 7 and 21
postterm was observed to be 100% in cages with (
 
n 
 
  
 
14) or
without (
 
n 
 
  
 
10) fucose supplementation.
 
Fucosylated glycans are present in FX(
 
 
 
/
 
 
 
) embryos, 
but are not synthesized by FX(
 
 
 
/
 
 
 
) cells
 
In an effort to understand the apparent inability to rescue
FX(
 
 
 
/
 
 
 
) embryos with maternal fucose supplementation,
we sought to determine if fucosylated glycans are present
in FX(
 
 
 
/
 
 
 
) embryos collected from FX(
 
 
 
/
 
 ) mothers
reared and gestated in the absence of fucose. Glycans that
contribute to fucosylation-dependent E-selectin ligand ac-
tivities on mouse neutrophils (Maly et al., 1996; Homeis-
ter et al., 2001) were used to assess fucosylation at 18.5
dpc in the spleens of wild-type (WT) embryos and FX( / )
embryos, and in the spleen of a strain of doubly fuco-
syltransferase-deficient mice that maintains a WT FX lo-
cus (Fig. 3; Homeister et al., 2001). An E-selectin–IgM
immunohistochemical probe identifies such ligands in the
neutrophil-rich (Gr-1–positive) spleens of WT embryos,
whereas the chimera does not bind to the spleen in the fu-
cosyltransferase-deficient embryo. In an FX( / ) em-
bryo, splenocytes retain E-selectin–IgM chimera binding.
Identical results have been observed in both other inde-
pendently studied FX( / ) embryos (unpublished data).
Therefore, synthesis of fucosylated glycans can proceed in
at least some FX( / ) embryos in utero, even if the het-
erozygous mother is gestated on a standard diet. This ob-
servation is consistent with the possibility that the par-
tially penetrant embryonic lethality associated with this
genotype may be accounted for by fucosylation-indepen-
dent mechanisms, or that subnormal fucosylation not de-
tected by immunohistochemical methods contributes to
decreased intrauterine viability (see Discussion). These
observations do not exclude the possibility that fucosyla-
tion competency varies, genetically or otherwise, among
FX( / ) embryos, and that fucosylation competency
may correspond to and account for survival in utero be-
cause we may only have sampled fucosylation competent
embryos destined for survival, and not fucosylation in-
competent embryos, either by chance, or because these
perish prior to the 18.5 dpc sampling time.
FX-independent expression of fucosylated glycans in the
FX-null embryos in this experiment suggests either that fu-
cose is being supplied via the maternal circulation, or by
WT or heterozygous sibling fetuses in utero, or that an as yet
unknown FX-independent pathway for GDP–fucose syn-
thesis is active in the cells of FX( / ) embryos. To address
this latter possibility, fibroblasts prepared from FX( / )
embryos were propagated in vitro and examined by flow cy-
tometry for their ability to support cell surface fucosylation
when grown in the absence of exogenous fucose, or in media
supplemented with fucose to a concentration (22  M) pre-
dicted to exist in the serum of rodents reared on fucose-sup-
plemented chow (Fig. 4; Sima et al., 1997). Pea lectin
(Pisum sativum agglutinin [PSA]), a reagent that recognizes
certain  (1,6)-fucosylated N-glycans (Kornfeld et al., 1981),
binds to WT (Fig. 4) and FX( / ) (unpublished data) em-
bryonic fibroblasts, but does not bind to FX( / ) embry-
onic fibroblasts grown in the absence of exogenous fucose
(Fig. 4). Nonetheless, FX( / ) fibroblasts retain an intact
salvage pathway for GDP–fucose synthesis and are compe-
tent to construct cell surface fucosylated glycans, as PSA
binding is restored when they are grown in media supple-
mented with fucose (Fig. 4). These observations confirm
that nullizygosity for the FX locus disables the constitutive
pathway for synthesis of GDP–fucose from GDP–mannose,
and diminish but do not exclude the possibility that an alter-
native fucose-independent pathway for GDP–fucose synthe-
sis accounts for the fucosylated cell surface glycans detected
in some FX( / ) embryos. These results also imply that
the GDP–fucose salvage pathway in such embryos may be
nourished in utero by maternally or fraternally derived fu-
cose or fucosylated glycans.
Table III. Progeny of FX( / )   FX( / ) intercross
Genotype Male  Female Total  % Observed % Expected
 /  33 26 59 55.1 25
 /  18 28 46 43 50
 /  2 0 2 1.9 25
Cage water was supplemented with fucose to a final concentration of 100
mM. Genotypes of progeny mice were determined at weaning (postnatal
day 21). Chi-square analysis was used to compare the observed values with
the values predicted by Mendelian inheritance patterns. P   10
 3.
Figure 4. Expression of fucosylated glycans on 
FX( / ) embryonic fibroblasts. Fibroblasts from 
an FX ( / ) embryo and a WT littermate were 
propagated in standard media or in media 
supplemented with 22  M fucose, stained with FITC-
conjugated PSA, and analyzed by flow cytometry 
(Materials and methods). PSA binding was 
inhibited by preincubation of PSA with 100 mM 
mannose.806 The Journal of Cell Biology | Volume 158, Number 4, 2002
Increased rate of survival of FX( / ) embryos
in the progeny of FX( / )   FX( / ) matings, 
and FX( / ) intercrosses
Rare viable FX( / ) progeny of the FX( / ) intercrosses
were runted, and died shortly (2–3 wk) after weaning. In an
attempt to rescue these rare FX( / ) individuals, FX( / )
progeny obtained from FX( / ) mothers gestated on fu-
cose-supplemented water were weaned to chow and water
that were supplemented with fucose. Two such individuals,
both males, survived to and thrived in adulthood on the fu-
cose-supplemented diet. Reasoning that if these founders
were fertile, mating with heterozygous females might in-
crease the number of FX( / ) embryos per uterus eligible
for survival, and would in principle double the number of
viable FX( / ) individuals available for study. However,
surprisingly, matings between FX( / ) females and the
two founder FX( / ) males (reared from weaning on a fu-
cose supplemented diet) yielded an  2:1 ratio of FX( / )
and FX( / ) genotypes among the progeny, with normal
sized litters, and an equal distribution of sexes. This ratio
was not appreciably altered by supplementing the maternal
diet with fucose prior to and during gestation (Table IV).
Furthermore, matings between FX( / ) males and females,
both reared on a fucose-supplemented diet, also yielded nor-
mal sized litters containing equal numbers of male and fe-
male FX( / ) progeny. These observations, and the fact
that the complex geneology of the FX( / ) founder line is
characterized by variable contributions by the C57BL/6J
and 129S2/ SvPas genomes (Becker, 2002; unpublished
data), are consistent with the possibility that one or more
modifier loci contribute to survival of FX( / ) animals
(unpublished data), or that the intrauterine distribution of
FX genotypes determines the relative survival potential of
FX( / ) embryos (see Discussion).
Fucose-dependent restoration of health, viability, and 
cellular fucosylation in FX( / ) mice
FX( / ) mice are small at weaning, but overcome this def-
icit by 6 wk of age when reared on a fucose-supplemented
diet (Fig. 5 A). The fucose-supplemented diet yields a mod-
est but reproducible suppression of weight gain in heterozy-
gotes (Fig. 5 B) and in WT mice (unpublished data). Its
cause is not known. Male and female FX( / ) mice have
normal life spans through the first 2 mo of life (Fig. 5 B),
and have grossly normal overall general health when pro-
vided with a fucose-supplemented diet. By contrast, FX( / )
mice reared on standard laboratory chow remain smaller
that WT or fucose-fed FX( / ) littermates (Fig. 5), and
consistently suffer from a clearly evident diarrhea. Diarrhea
does not occur in FX( / ) mice reared from birth on a fu-
cose-containing diet, but reversion to a standard chow diet
leads to onset of diarrhea an average of 16 d later, and termi-
nates within 9 d of resuming a fucose-supplemented diet.
Diarrhea is associated with colonic histopathology character-
ized by a thickened mucosa, crypt destruction and distor-
tion, crypt abscesses, regenerative crypt and surface epithe-
lium, and a mixed inflammatory cell infiltrate within the
lamina propria. This histopathology is reversed by restora-
tion of fucose supplementation, and is characteristic of
inflammatory bowel disease (Fig. 6; Allison et al., 1998).
Diarrhea is accompanied by evidence for dehydration, char-
acterized by a “tenting” of the animal’s skin and a 48% aver-
age increase in serum creatinine, which may account for
their extreme lethargy and short lifespan. Diarrhea and ab-
normal colon histopathology are not characteristic of mice
with deficiencies in Fuc-IV and/or Fuc-TVII (Homeister et
al., 2001; unpublished data), indicating that selectin ligand
deficiencies in these mice, and in the FX( / ) mice (see be-
low) do not, per se, account for inflammatory bowel disease
syndrome in FX( / ) animals.
Male and female FX( / ) mice are infertile when reared
in the absence of fucose. FX( / ) males reared from birth
on a fucose-supplemented diet and with documented fertil-
ity become completely infertile  6 wk after transfer to a
standard diet despite an apparently normal mating ability at
this time. Fertility is restored within 4 wk after return to fu-
cose supplementation. Fucose-dependent fertility in female
FX( / ) mice follows a similar pattern.
Table IV. Progeny of FX( / )   FX( / ) cross
 /   /  P value
a
No exogenous fucose in chow or water 35 13  10
 3
Fucose supplemented chow and water 96 48  10
 3
Genotype of progeny mice were determined at weaning (postnatal day 21).
aThe binomial probability (z) was calculated based on the expected Men-
delian frequency of 50% ( / ) and used to calculate the two-tailed P
value.
Figure 5. Growth and survival of FX( / )-null mice as a function 
of fucose supplementation. (A) weight (mean   SE), measured 
weekly starting 7 d after birth, of WT ( ), FX( / ) ( ), and FX( / ) 
mice ( ) maintained on water supplemented with 100 mM fucose 
and chow supplemented with fucose (5% wt/wt), or FX( / ) (  ) 
and FX( / ) ( ) mice provided with fucose-free water and chow. 
Approximately equal numbers of male and female mice were 
evaluated. Only animals that survived the entire 9-wk monitoring 
period are included in the data. (B) Kaplan-Meier survival analysis. 
FX( / ) mice were weaned at 3 wk and reared on normal chow 
and water, or on fucose-supplemented water and chow as in A.Conditional control of fucosylation in FX-null mice | Smith 807
In FX( / ) mice, restoration to health with a fucose-
supplemented diet implies that a relative or complete defi-
ciency of FX-dependent GDP–fucose synthesis and cellular
fucosylation accounts for failure to thrive. Immunohis-
tochemistry was used to determine if the glycans in the tis-
sues of adult FX( / ) mice reared in the absence of fucose
are deficient in fucose modifications, and if fucose supple-
mentation circumvents this defect. In the mouse liver, a site
of synthesis of  (1,6)-fucosylated glycans (Havenaar et al.,
1998; Miyoshi et al., 1999), Aleuria aurantia agglutinin, a
lectin highly specific for  (1-6)-linked fucose, binds to the
N-glycans in WT mice reared on a standard diet, but binds
to the N-glycans in FX( / ) mice only when they are
reared on a fucose-supplemented diet (Fig. 7 A). In the high
endothelial venules (HEVs) of peripheral lymph nodes,
where O-linked  (1,3)-fucosylated glycans contribute to the
adhesive activities of L-selectin counter receptors (Maly et al.,
1996), an L-selectin–IgM chimera binds to HEVs in WT
mice reared on a standard diet, but binds to FX( / )
HEVs only when their diet is supplemented with fucose
(Fig. 7 B). These observations imply that the N- and
O-linked glycans in FX( / ) mice are deficient in fucose
modification unless the salvage pathway is supplied with ex-
ogenous fucose.
Conditional expression of neutrophil E- and P-selectin 
counter receptor activities in FX( / ) mice
Fucosylation on O-glycans (Wilkins et al., 1996) and N-gly-
cans (Steegmaier et al., 1995) also provides a primary
contribution to the adhesive activities of leukocyte E- and
P-selectin counter receptors (Maly et al., 1996; Homeister
et al., 2001). To examine the hematological consequences of
the conditional fucosylation deficiency characteristic of the
FX( / ) mouse in this context, leukocyte selectin ligand
activities were assessed in these mice as a function of fucose
repletion. In FX( / ) mice raised on a standard diet, flow
cytometry analysis of blood neutrophils discloses an absence
of E- or P-selectin ligand activities (while retaining expres-
sion of the P-selectin ligand PSGL-1; unpublished data) and
profoundly defective fucosylation of their surface-localized
N-glycans (while retaining expression of complex N-glycans
detected with concanavalin A; unpublished data) (Fig. 8 A).
Figure 6. Histology of the descending colon. The two panels at top depict the histology of the full thickness of the wall of colons extirpated 
from WT mice fed normal laboratory chow (top left), and from FX( / ) mice fed fucose-supplemented chow (2.5% wt/wt) (top right). The 
wall of the colon in FX( / ) mice reared in the absence of fucose is roughly twice the normal thickness, necessitating separate panels that 
display the basal (bottom left) and lumenal (bottom right) aspects of the fucose-deficient FX( / ) colon wall. Black arrows identify crypt 
abscesses. Red arrows delimit areas of mixed inflammatory cell infiltrate that expand the lamina propria, including a plasma cell infiltrate 
beneath the base of and between crypts. Hematoxylin and eosin stain.808 The Journal of Cell Biology | Volume 158, Number 4, 2002
However, full restoration of neutrophil E- and P-selectin
ligand activities and N-glycan fucosylation are observed in
FX( / ) mice provided with cage water or chow supple-
mented with fucose at levels used in efforts to rescue embry-
onic lethality (Fig. 8 A). When FX( / ) mice raised on a
standard diet are provided with water supplemented with
2.5 mM fucose 3 d before phlebotomy, modest restoration
of P-selectin ligand activity and N-glycan fucosylation is ob-
served, whereas E-selectin ligand activity remains apparently
absent. Small amounts of E-selectin ligand activity first be-
come detectable by flow cytometry in mice provided with 5
mM fucose in water, and are accompanied by increased ex-
pression of P-selectin ligand activity and N-glycan fucosyla-
tion, relative to levels observed with 2.5 mM supplemen-
tation. With 10 mM fucose supplementation, virtually
normal expression of P-selectin ligand activity and N-glycan
fucosylation are observed, whereas E-selectin ligand activity
is not fully reconstituted. An assessment of the E- and
P-selectin–mediated shear-dependent adhesion of these
neutrophils also demonstrates a dissociation between the
relative degree of restoration of E- and P-selectin counter re-
ceptor activities (Fig. 8 B). This more sensitive approach for
detecting E- and P-selectin ligand activities (Homeister et
al., 2001) also discloses residual E-selectin ligand activity at
2.5 mM fucose supplementation not evident in the flow cy-
tometry analysis (Fig. 8 B).
Mechanisms remain to be defined to account for the ap-
parent differential reconstitution of P-selectin ligand activ-
ity, relative to restoration E-selectin ligand activity, at
certain low levels of fucose supplementation. These mecha-
nisms are likely to be a complex function of the number and
site(s) of the fucose moieties required to reconstitute P- and
E-selectin ligand activities on specific E- and P-selectin
counter receptors, and perhaps of the relative efficiencies
with which these sites are fucosylated at any given GDP–
fucose concentration. Regardless of mechanism, these ob-
servations suggest that cellular control of GDP–fucose
availability has the potential to differentially regulate the
functionality of distinct fucosylated cell surface glycans, as
inferred for events involving CMP–sialic acid-dependent
sialylation (Keppler et al., 1999) and UDP-galactose–depen-
dent galactosylation (Toma et al., 1996). The faster and
greater restoration of P-selectin ligand activity, relative to
E-selectin ligand activity, in a LAD-II patient treated with
fucose (Marquardt et al., 1999) also supports this notion.
Together with the results obtained with the lectin and
Figure 7. Expression of fucosylated glycans in the liver and peripheral lymph node high endothelial venules. A. Frozen sections of livers 
stained with Aleuria aurantia lectin (Materials and methods). Livers were isolated from WT mice fed standard laboratory chow (WT, off fucose), 
FX( / ) mice fed standard laboratory chow (FX[ / ], off fucose), or FX( / ) mice reared on chow containing 5% wt/wt fucose (FX[ / ], 
on fucose). Staining was blocked with fucose in the (WT, off fucose, blocked) panel (Materials and methods) (bright light photomicrography 
at 20  magnification). (B) Frozen sections of peripheral node high endothelial venules stained with MECA-79 or an L-selectin–IgM chimera. 
Axillary lymph nodes were isolated from WT mice fed standard laboratory chow (WT, off fucose), FX( / ) mice fed standard laboratory 
chow (FX[ / ] off fucose), or FX( / ) mice fed standard laboratory chow, and then supplied with 100 mM fucose in their drinking water
3 d before sacrifice (FX[ / ], on fucose). Serial frozen sections of axillary lymph nodes were stained with MECA-79 or an L-selectin–IgM 
chimera as described (Maly et al., 1996) (fluorescent photomicrography at 40  magnification).Conditional control of fucosylation in FX-null mice | Smith 809
L-selectin–IgM chimera staining (Fig. 7), these observations
indicate that a virtually complete fucosylation deficiency ex-
tends to many organs in FX( / ) mice, and can be reliably
circumvented via the salvage pathway and exogenous fucose.
Conditional modulation of blood leukocytosis 
in FX( / ) mice
Defects in the selectin receptor/counter receptor couple lead to
deranged homeostasis in blood leukocyte number (Frenette et
al., 1996; Maly et al., 1996; Robinson et al., 1999; Homeister
et al., 2001). Although homeostasis is inferred to be a function
both of selectin ligand-dependent clearance of leukocytes, and
production of leukocytes by their marrow-derived progenitors
(Johnson et al., 1995; Frenette et al., 1996; Levesque et al.,
1999; Homeister et al., 2001), the relative contributions of
these two processes, and the temporal range over which each
process contributes are not understood. The conditional nature
of the neutrophil selectin ligand defect in FX( / ) mice, with
the potential to rapidly induce or extinguish expression of se-
lectin ligands, presented an opportunity to examine and better
define the relative contributions of selectin ligand-dependent
leukocyte clearance and leukocyte production.
FX( / ) mice reared since weaning in the absence of fu-
cose exhibit a substantial blood leukocytosis, accounted for
by a 25-fold increase in neutrophils (Fig. 9 A). In these mice,
E- and P-selectin ligand activities are not detected on periph-
eral blood leukocytes (Fig. 8). In FX( / ) mice reared in
the absence of fucose, the neutrophilia is reduce by roughly
half within 8 h of oral fucose administration, to a level ap-
proximating that observed in mice deficient for fucosyltrans-
ferases VII and IV (Homeister et al., 2001). The rapid reduc-
tion in neutrophilia is precisely paralleled by the appearance
in the blood of a population of neutrophils that are P-selectin
ligand positive and that comprise a majority of circulating
neutrophils (Fig. 9 B). Some of the circulating neutrophils
also express E-selectin ligands at this time, though these are
fractionally fewer than the P-selectin ligand positive neutro-
phils, in keeping with the observation that E-selectin ligand
activity is less complete than P-selectin ligand activity when
examined under limiting conditions of fucose supplementa-
tion (Fig. 8). 16 h after fucose repletion, the neutrophilia is
further reduced, and E- and P-selectin ligands are now ex-
pressed on an equal and nearly normal fraction of these circu-
lating cells. By 24 h, E- and P-selectin ligands are expressed
on the majority of blood neutrophils, as observed in WT
mice (Maly et al., 1996) or in FX( / ) mice reared from
birth on fucose (Fig. 9 B). Rapid restoration of the blood
neutrophil count to a near normal level thus parallels restora-
tion of E- and P-selectin ligand activities. When considered
together with the inferred role for selectins and their ligands
Figure 8. Control of granulocyte selectin ligand expression with exogenous fucose. FX( / ) mice were reared on 5% fucose-containing chow 
until 8 wk of age and then removed from exogenous sources of fucose for 7 d. The mice were then reintroduced to cages containing standard chow, 
and water containing the indicated concentration of fucose, or to cages containing 5% fucose-supplemented chow. Mice were killed three days 
later, and their peripheral blood neutrophils were subjected to flow cytometry analysis (A), or to controlled detachment assays in a parallel plate 
flow chamber (B). Peripheral blood leukocytes isolated from WT mice reared on standard chow were analyzed in parallel. For flow cytometry (A), 
blood leukocytes were stained with anti-Gr-1, and E- or P-selectin-IgM chimeras (without EDTA, solid line; with EDTA, dotted line), or PSA (without 
100 mM mannose, solid line; with mannose, dotted line) (Materials and methods). In parallel plate flow chamber assays (B) (Materials and methods), 
purified blood neutrophils were allowed to settle for 2 min onto the selectin-IgG–coated plate (P-selectin   38 sites/ m
2; E-selectin   47 sites/ m
2) 
at 1 g, and were subjected to step-wise increments in shear flow lasting 30 s each. Cells remaining after each 30-s interval were quantitated by video 
microscopy and plotted as the fraction of cells present following initial static attachment.810 The Journal of Cell Biology | Volume 158, Number 4, 2002
in determining the circulating half-life of a neutrophil
(Johnson et al., 1995; Homeister et al., 2001), these observa-
tions imply that a major determinant of the neutrophila in
FX( / ) mice is a prolonged half-life, and that this half-life,
and thus the number of circulating neutrophils, is restored by
fucose-dependent reconstitution of selectin ligand expression.
Circulating selectin ligand-deficient neutrophils generated
by the marrow prior to fucose supplementation may convert
to selectin ligand positivity acutely after fucose repletion, as
selectin ligand activity on FX( / ) neutrophils is partially
restored when incubated in vitro in fucose-supplemented
media (Fig. 9 C). In the marrow, E- and P-selectin ligand
expression on Gr-1–positive myeloid lineage cells plateaus
within 16 h of fucose administration, reaching near normal
levels, and slightly anticipating full restoration of E- and
P-selectin ligand expression in the periphery (Fig. 9 D).
These observations imply that a substantial fraction of the
selectin-ligand positive neutrophils in the periphery repre-
sent cells newly formed by fucose-repleted progenitors in the
marrow, and then released rapidly into the circulation. The
order of restoration of E- and P-selectin ligands on marrow
cells is opposite to that observed in the periphery, suggesting
that some of these E-selectin ligand positive marrow cells
may not reach the periphery.
The myeloid–erythroid (M/E) ratio in the marrows of
FX( / ) mice reared in the absence of fucose is increased
by more than twofold (Fig. 9 E), and is accompanied by a
nearly twofold increase in colony-forming unit–granulocyte
macrophage (CFU-GM), the mature subsets of myeloid
progenitor cells that respond to stimulation by GM–colony-
stimulating factor or M-CSF (Fig. 9 E). The number of
CFU-GM is reduced by half at 24 h, and normalizes by 48 h
after fucose repletion, whereas the M/E ratio normalizes be-
tween 48 and 96 h later. To the extent that the lineage-com-
mitted progenitor cells represented by the CFU-GM pool
correlate with the granulocyte production by the marrow,
these observations imply that selectin ligand deficits, or defi-
cits in other fucose-dependent processes in the marrow, are
accompanied by aberrant proliferation of myeloid progeni-
tors and an increased production of granulocytes that
contributes to the neutrophilia. Normal numbers of burst-
forming unit–erythroid and CFU–granulocyte-erythroid-
megakaryocyte-macrophage are present in the marrows of
the FX( / ) mice, and do not vary as a function of fucose
repletion (unpublished data), suggesting that defective fuco-
sylation does not significantly perturb homeostasis of com-
mitted erythroid lineage progenitors, nor of more primitive
multipotent progenitors.
In FX( / ) mice a modest neutrophilia persists at 24 h
after the initiation of fucose supplementation, remains for at
least 4 d, but returns gradually to a normal level over a pe-
riod of three or more weeks (unpublished data). Because se-
lectin ligand expression has fully normalized by 24 h, and
the CFU-GM and M/E ratio normalize within 96 h, these
observations imply the existence of fucose-dependent pro-
cesses that directly or indirectly determine blood neutrophil
homeostasis, and that are not yet apparent from our analysis
of the marrow or peripheral blood leukocytes.
The virtually normal neutrophil counts observed in FX( / )
mice reared from weaning on a fucose-replete diet give way
to a neutrophilia when these mice are fed a standard diet
(Fig. 10 A). A modest neutrophilia is apparent within 3 d af-
ter termination of fucose supplementation, corresponding to
the loss of selectin ligand-positive neutrophils (Fig. 10 B),
and gradually increases over the ensuing 12 d. In the marrow,
the number of CFU-GM remains normal during the first day
after fucose withdrawal, then increases by 3 d to the roughly
twofold elevation observed in chronic absence of fucosyla-
tion, in approximate correlation with an increase in the M/E
ratio and onset of neutrophilia (Fig. 10 C). The more gradual
onset of peripheral and marrow hematopoietic abnormalities
upon fucose withdrawal may in part reflect the pace of re-
placement of fucosylated cellular and extracellular glycopro-
teins with nonfucosylated versions that no longer sustain
hematopoietic homeostasis. During glycoprotein turnover,
endocytosis (Mukherjee et al., 1997) and autophagy (Klion-
sky and Emr, 2000) deliver fucosylated glycoproteins and
glycolipids to the lysosome, where lysosomal hydrolases that
include   -fucosidase (Winchester, 1996) liberate fucose.
Transport of this fucose into the cytosol (Jonas et al., 1990),
and utilization by the salvage pathway, may prolong the pace
of replacement with nonfucosylated glycans.
Discussion
Mutant cell lines with deficiency in GDP-mannose 4,6-
dehydratase (GMD), the first enzyme in the de novo path-
way (Fig. 1), do not elaborate fucosylated glycans (Reitman
et al., 1980; Ripka et al., 1986). Quantitative studies in
HeLa cells also indicate that the de novo, mannose-depen-
dent pathway accounts for the vast majority of cellular
GDP–fucose production (Yurchenco and Atkinson, 1977).
FX-deficient mammalian cell lines have not been previously
described; however, as demonstrated here, targeted disrup-
tion of the FX locus in the mouse ablates the de novo path-
way for GDP–fucose synthesis from GDP–mannose (Fig.
1), creating an animal that is entirely dependent on exoge-
nously supplied fucose for cellular fucosylation. FX( / )
adult animals exhibit a virtually complete absence of fucosy-
lated glycans in multiple tissues that can be intentionally re-
versed by modulation of dietary fucose.
The situation is more complex in the embryo. Because fi-
broblasts derived from FX( / ) embryos exhibit a complete
deficiency in fucosylation unless supplied with exogenous fu-
cose (Fig. 4), the existence of fucosylated glycans in FX( / )
embryos gestated in FX( / ) mothers fed standard labora-
tory chow suggests that fucosylation derives from maternal
or fraternal sources. Though free serum fucose concentra-
tions are not known in mice, micromolar quantities of
nonprotein associated fucose are present in the serum of rats
(Sima et al., 1997). Transplacental delivery of free fucose
from maternal serum to FX( / ) embryos, or from FX( / )
or FX( / ) siblings, perhaps via a specific plasma mem-
brane transporter (Wiese et al., 1994), could supply the sal-
vage pathway for GDP–fucose synthesis in developing em-
bryos. FX( / ) embryos may also be supplied with fucose
via transcytotic or endocytotic delivery of maternal fucosy-
lated glycoconjugates to the embryo, via the placenta. Fucose
released from these molecules by lysosomal catabolism, and
delivered to the cytosol by a lysosomal fucose transport sys-Conditional control of fucosylation in FX-null mice | Smith 811
tem (Jonas et al., 1990), could also supply the salvage path-
way. The existence of maternal-fetal fucose transport remains
to be established, and it is not known if systems like the pla-
cental IgG transport system (Mostov, 1994) can deliver
meaningful amounts of maternally-derived fucosylated gly-
coconjugates to the catabolic machinery of the embryo. Our
observations imply the existence of such pathways.
The embryonic lethal phenotype characteristic of FX( / )
mice is unusual. Fucosylated glycans are widely expressed in
the mouse embryo (Sato et al., 1986), have been assigned es-
sential roles in implantation (Kimber, 2000), and blastocyst
compaction (Fenderson et al., 1984), and their absence early
in development might have been suspected to lead to ad-
verse or lethal consequences. Mice that are homozygous for
null alleles at loci encoding the  (1,3)fucosyltransferase Fuc-
TIV, Fuc-TVII, or both (Maly et al., 1996; Homeister et al.,
2001), or in the  (1,2)fucosyltransferases FUT1 or FUT2
(Domino et al., 2001) survive to term at a normal rate. The
low frequency of FX( / ) progeny from an FX( / ) in-
tercross might therefore be ascribed to deficiencies in fuc-
osylation events determined by  (1,3)fucosyltransferase
Fuc-TIX (Kudo et al., 1998), by  (1,6)fucosyltransferase
Fuc-TVIII (Miyoshi et al., 1999), by one or more serine/
threonine fucosyltransferases (Harris and Spellman, 1993),
or by candidate fucosyltransferases yet to be characterized
(Roos et al., 2002).
However, fucosylated glycans are detected in FX( / )
embryos generated from an intercross of FX( / ) mice, a
circumstance associated with highly penetrant embryonic le-
thality (Table I). Maternally derived fucose may restore cellu-
lar GDP–fucose to a level sufficient for appropriate fucosyla-
tion of some glycoproteins and glycolipids, but not others
whose fucosylation may be essential for function, and perhaps
embryonic viability. The fact that a low level of fucose supple-
Figure 9. Peripheral blood leukocyte kinetics during fucose restoration. FX( / ) mice were maintained on standard chow and water from 
weaning until 8 wk of age. Mice were introduced to water containing 100 mM fucose and peripheral blood was collected from the retroorbital 
plexus 8–96 h later. Data from 6-wk-old FX( / ) mice reared from birth in cages containing 0.5% wt/wt fucose supplemented chow are 
indicated by “ .” Data from WT or Fuc-TIV( / )/Fuc-TVII( / ) mice (Homeister et al., 2001) reared on standard chow are also shown. 
Data are mean values   SEM of at least three determinations. (A) Blood neutrophil counts. (B) The fraction of Gr-1–positive peripheral blood 
leukocytes that stain with an E-selectin–IgM or P-selectin–IgM chimera. (C) Fucose-dependent restoration of neutrophil P-selectin ligand 
activity in vitro. Neutrophils were isolated from WT or FX( / ) mice reared on standard chow, were incubated for 8 h in vitro in the absence 
of added fucose (  fucose in vitro) or in media supplemented with fucose to a concentration of 22 mM (  fucose in vitro), and were 
subjected to flow cytometry analysis after staining with anti–Gr-1 and an E- or P-selectin–IgM chimera. The fraction of leukocytes that fall into 
each quadrant are indicated by numbers in the histograms. (D) The fraction of Gr-1–positive bone marrow cells that stain with an E-selectin–
IgM or P-selectin–IgM chimera. (E) CFU-GM and myeloid/erythroid ratios (M/E) on bone marrow cells.812 The Journal of Cell Biology | Volume 158, Number 4, 2002
mentation restores P- but not E-selectin ligand expression on
neutrophils in the FX( / ) mice, and the observation that
fucose treatment of a LADII patient yields greater restoration
of P-selectin binding relative to E-selectin binding (Mar-
quardt et al., 1999) provide precedents for this possibility.
Alternatively, the GDP–fucose salvage pathway may not
be active in all cell types, in utero or otherwise, leaving such
cells, in FX( / ) mice, vulnerable to a complete deficiency
of fucosylation. We do not know if the salvage pathway is
absent from some cells, or if there are cell types for which a
complete defect in fucosylation will confer lethality upon an
embryo. It seems unlikely that the product of the GMD pro-
tein, GDP-4-keto-6-deoxymannose (Sullivan et al., 1998) or
its unknown metabolites which might accumulate in FX( / )
embryos, are toxic and account for intrauterine demise, as
FX( / ) embryos appear to be produced in normal num-
bers in FX( / ) intercrosses. Other fucosylation-indepen-
dent mechanisms that might account for the lethal embry-
onic phenotype remain to be identified and tested.
The results of crosses between FX( / ) and FX( / )
mice (Table IV) and intercrosses of FX( / ) mice indi-
cate that parental genotype at the FX locus correlates with
the penetrance of the embryonic lethality associated with
nullizygosity at the FX locus. These data, and the derivation
of the FX( / ) colony from two surviving male FX( / )
males, via a complex and interbred geneology are also consis-
tent with the possibility that segregation of one or more
modifier alleles derived from either the C57BL/6J or 129/Sv
ancestors of the FX( / ) mice may suppress or authorize
embryonic lethality when segregating with FX null alleles.
This notion is strongly supported by our recent observation
that matings between FX( / ) mice obtained after 12 gen-
erations of backcrossing to the C57BL/6J strain yield FX( / )
progeny at a nearly Mendelian rate (unpublished data). Isola-
tion of such strain-specific modifier loci may prove instruc-
tive in understanding the contributions of fucosylated glyco-
conjugates to development and differentiation.
Parallels between the phenotype we observe in the FX( / )
mice and those observed in LAD-II, a human disorder of
fucosylation consequent to mutations in the Golgi GDP–
fucose transporter locus (Lubke et al., 2001; Luhn et al., 2001),
extend to the ability to correct the fucosylation defects in
culture with fucose (Karsan et al., 1998), and for one LAD-
II pedigree, restoration of leukocyte selectin ligands with
oral fucose administration (Marquardt et al., 1999). FX defi-
ciency and LAD-II are also characterized by a rather nonspe-
cific growth deficiency, but it remains to be determined if
the dysmorphology and psychomotor retardation character-
istic of LAD-II have parallels in FX deficiency. However,
colitis is not a prominent feature of LAD-II, and there is dis-
cordance between the embryonic lethality seen in FX( / )
intercrosses and an apparent absence thereof in heterozygous
matings within LAD-II pedigrees (Becker and Lowe, 1999).
Lack of phenotypic overlap in these and other contexts may
be ascribed to the fact that the FX( / ) mice are com-
pletely dependent upon the salvage pathway for GDP–
fucose availability, whereas residual GDP–fucose transport
activity characteristic of the hypomorphic transporter defi-
Figure 10. Peripheral blood leukocyte kinetics following fucose deprivation. FX( / ) mice reared from weaning until 8 wk of age on chow 
that included 5% wt/wt fucose were placed in cages containing standard chow, and peripheral blood was collected from the retroorbital 
plexus 1, 3, 5, 8, and 12 d later. Data from FX( / ) mice reared from birth in cages with standard chow are indicated by “ .” Data are mean 
values  SEM of three determinations (panels A and B) or between three and eight determinations (C). (A) Blood neutrophil counts. (B) The 
fraction of Gr-1–positive peripheral blood leukocytes that stain with an E-selectin–IgM or P-selectin–IgM chimera. (C) CFU-GM and M/E 
ratios on bone marrow cells.Conditional control of fucosylation in FX-null mice | Smith 813
ciencies is likely to support some level of fucosylation in
utero and post-natally, with the caveat that it is not yet
known if deficiencies at these two loci also yield fucosyla-
tion-independent events that contribute to phenotype.
Fucose modifies the EGF-like domains of some blood
clotting proteins (Harris and Spellman, 1993) and the
Notch family of transmembrane receptors (Moloney et al.,
2000a) through the hydroxyls of serine and threonine resi-
dues. Members of the Fringe family of N-acetylglucosami-
nyltransferases require this fucose modification to construct
a Notch-associated glycan that modulates signal transduc-
tion events initiated by Notch ligands (Bruckner et al., 2000;
Moloney et al., 2000b). These considerations imply that
Fringe-dependent Notch signaling will be perturbed in
FX( / ) mice, and suggest that conditional control of ex-
pression of this elongated glycan in these animals may be
used to further define the roles for Fringe-dependent control
of Notch signaling in lymphoid development (Deftos and
Bevan, 2000), hematopoiesis (Milner and Bigas, 1999), epi-
thelial cell differentiation (Lowell et al., 2000), vertebrate
somitogenesis (Evrard et al., 1998; Zhang and Gridley,
1998), and the general establishment of developmental
boundaries during development (Irvine, 1999).
Materials and methods
Generation of targeted embryonic stem cell lines
A targeting vector constructed from the murine FX locus (Szikora et al.,
1990; Camardella et al., 1995) contains  2.45 and 2.10 Kb of the 5  and
3  ends, respectively, of the FX locus isolated from the 129/Sv mouse
strain. D3 embryonic stem cells (129S2/SvPas; Simpson et al., 1997) were
transfected, selected, and maintained as described (Maly et al., 1996). Cor-
rectly targeted embryonic stem cells were identified by Southern blot anal-
ysis using a 427-bp fragment amplified by the polymerase chain reaction
(5  primer: TTGCAGGATAAGAACTGGAGATTCCTTGCC; 3  primer:
AGACCCACAATGCGAGACGTACTCTTACGG) from genomic DNA lo-
cated external to the 5  end of the targeting construct to probe EcoRI-digested
genomic DNA (Probe A, Fig. 2 A, 8.9-Kb WT allele, 3.2-Kb mutant allele).
Correct homologous integration was confirmed by probing the same blot
with a 320-bp fragment amplified from genomic DNA located external to
the 3  end of the targeting construct (Probe B, Fig. 2 A, 8.9-Kb WT allele,
4.3-Kb mutant allele; data not depicted). Deletion of exons 4 and 5 was
confirmed by probing the same blot with a 455-bp Sac I-Msp I fragment
(Probe C, Fig. 2 A, 8.9-Kb WT allele). Second site nonhomologous integra-
tion events were excluded by probing Southern blots with a fragment iso-
lated from the PGK-Neo cassette (Probe D, data not depicted).
Generation of FX( / ) mice
FX ( / ) embryonic stem cells were injected in C57BL/6J blastocysts, fol-
lowed by transfer into CD-1 pseudopregnant recipient females. Chimeric
males were crossed with C57BL/6J females. The mutant allele was identi-
fied in F1 progeny by Southern blot analysis of EcoRV digested genomic
DNA using probe A (Fig. 2 A, 9.0-Kb WT allele, 5.7-Kb mutant allele). FX-
null mice were established by mating FX ( / ) heterozygous mice supple-
mented with 100 mM fucose in sterile water ad libidum. FX( / ) and
FX( / ) mice were maintained in a nude mouse vivarium at The Univer-
sity of Michigan (Ann Arbor, MI). Embryonic FX( / ) mice were identified
using the polymerase chain reaction and genomic DNA template (Fig. 2 A,
primer 1: TCACAGCAGCAATTTCGGGTACTCATACGC; primer 2: TGT-
ACTCCCGTAGGACCCAGATGAAGAGCC; primer 3: GGACTGGCTGC-
TATTGGGCGAAGTG; WT allele generates a fragment of 1040-bp, null al-
lele generates a fragment of 1100 bp).
Fucose supplementation
Mice were maintained on either Modified Lab Chow (product #5723C-A;
Purina Test Diets) containing 5% (mating) or 0.5% (maintenance) (wt/wt)
fucose (Pfanstiehl), or sterile water containing 100 mM fucose, or both,
supplied ad libidum. To assess leukocyte selectin ligand expression and
blood leukocyte counts after acute fucose repletion, 200  l of 0.5 M fu-
cose in endotoxin-free normal saline was administered by tail vein injec-
tion, and the mouse was immediately placed into a cage with water sup-
plemented to 100 mM fucose.
Flow cytometry of embryonic fibroblasts
Embryonic fibroblasts were prepared from 14.5 dpc embryos as described
(Robertson, 1987), and were incubated at 37 C in DME (Bio-Whittaker)
containing 15% fetal bovine serum,  22  M fucose. Cells were stained
with PSA-FITC (EY Laboratories; 1:600) and analyzed as described (Maly et
al., 1996).
Enumeration and analysis of blood and marrow leukocytes
Collection and flow cytometry analysis of selectin ligands on blood leuko-
cytes has been described (Maly et al., 1996). FITC-conjugated PSA
(1:1,000) and concanavalin A (1:50) were used   mannose (100 mM) or
 -methylmannoside (200 mM), respectively. Colony forming units in the
marrow were determined with a commercially available methylcellulose-
based procedure (StemCell Technologies, Inc.). Assay of controlled leuko-
cyte detachment in a parallel plate flow chamber was done as described
previously (Homeister et al., 2001). Restoration of neutrophil fucosylation in
vitro was done by incubating blood leukocytes for 8 h in DME containing
10% fetal calf serum   22  M fucose, followed by flow cytometry analysis.
Immunohistochemistry
Detection of HEV-born L-selectin ligands has been described (Maly et al.,
1996). Digoxigenin-labeled Aleuria aurantia lectin (5  g/ml; Roche) (Ya-
mashita et al., 1985) was used to stain frozen sections of liver. Digoxige-
nin-labeled lectin was visualized with peroxidase labeled anti-digoxigenin
antibody (0.75 units/ml; Roche). Spleens were examined in WT or FX ( / )
embryos obtained at 18.5 dpc from an FX( / ) mother sired by an FX ( / )
male, and gestated without fucose supplementation. Frozen sections (10
 m) were air dried, blocked with 2% BSA in TBS, pH 7.4, 2 mM CaCl2 and
0.02% azide, and stained with an E-selectin/IgM chimera (Maly et al.,
1996)   5 mM EDTA. The sections were washed with TBS/2 mM CaCl2 or
TBS/5 mM EDTA, and then incubated with biotin-conjugated goat anti–
human IgM followed by FITC-conjugated streptavidin (Pharmingen). Paral-
lel sections were stained with Gr-1 biotin-conjugated anti–Gr-1 (1:200;
Pharmingen), and Texas red–conjugated streptavidin (1:200; GIBCO BRL).
Sections were washed with TBS/2 mM CaCl2, fixed with 10% formalin,
washed with PBS, mounted with Citifluor AF1, and examined by fluores-
cence microscopy.
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